JP2019026599A - Method for producing effective ingredient holding sheet, device for producing effective ingredient holding sheet, and effective ingredient holding sheet - Google Patents

Abstract

To improve the biological efficacy of an effective ingredient holding sheet.SOLUTION: An effective ingredient liquid imparting part 17 imparts an effective ingredient liquid according to biological information to a sheet-like base material for impregnation.SELECTED DRAWING: Figure 3

Description

  The present invention relates to a method for producing an active ingredient holding sheet, an apparatus for producing an active ingredient holding sheet, and an active ingredient holding sheet.

  There is known an effective component holding sheet that holds an effective component for a living body and is attached to the living body to exert its effect.

  As such an active ingredient holding sheet, for example, Patent Document 1 discloses a face pack. This face pack is made by impregnating a fabric with a pack agent containing an active ingredient. By pasting this face pack on the user's face, the effect of the pack agent is exerted on the facial skin.

JP 2003-226633 A

  However, since a face pack such as Patent Document 1 is impregnated with a predetermined efficacy component, an appropriate efficacy according to the user's skin condition and the like may not be exhibited. Therefore, there has been a demand for enhancing the efficacy of the living body in the active ingredient holding sheet such as a face pack.

  The present invention has been made in view of the above, and an object of the present invention is to provide a method for producing an active ingredient holding sheet, an apparatus for producing an active ingredient holding sheet, and an active ingredient holding sheet that can enhance the efficacy for a living body.

  In order to achieve the above object, according to one aspect of the present invention, there is provided a method for producing an active ingredient-holding sheet to be attached to a living body, wherein the sheet-like base material is impregnated with an active ingredient liquid according to biological information. The manufacturing method of the active ingredient holding sheet | seat characterized by including the process to make is provided.

  According to another aspect of the present invention, there is provided a method for producing an active ingredient-holding sheet that is affixed to a living body, comprising a step of impregnating a sheet-like base material with a plurality of types of active ingredient liquids in different regions. A method for producing an active ingredient-holding sheet is provided.

  According to another aspect of the present invention, there is provided an apparatus for producing an active ingredient holding sheet to be attached to a living body, wherein the active ingredient is impregnated by applying an active ingredient liquid according to biological information to a sheet-like base material. There is provided an apparatus for producing an active ingredient-holding sheet comprising a liquid application unit.

  According to another aspect of the present invention, there is provided an apparatus for producing an active ingredient-holding sheet that is affixed to a living body, wherein a plurality of kinds of active ingredient liquids are applied to different regions and impregnated into a sheet-like base material. There is provided an apparatus for producing an effect ingredient-holding sheet comprising an effect ingredient liquid application unit.

  According to another aspect of the present invention, there is provided an active ingredient holding sheet to be attached to a living body, comprising a sheet-like base material, wherein the base material is impregnated with an active ingredient liquid according to biological information. The characteristic active ingredient holding sheet is provided.

  According to another aspect of the present invention, there is provided an active ingredient holding sheet that is affixed to a living body, comprising a sheet-like base material, wherein the base material is impregnated with different types of active ingredient liquids. There is provided an active ingredient holding sheet characterized in that a region is provided.

  ADVANTAGE OF THE INVENTION According to this invention, the effect with respect to the biological body by an active ingredient holding sheet can be improved.

It is a schematic block diagram of the face pack manufacturing apparatus which concerns on embodiment. It is a schematic block diagram of the print engine part of the face pack manufacturing apparatus shown in FIG. It is a control block diagram of the face pack manufacturing apparatus shown in FIG. It is explanatory drawing of face information. It is a flowchart of the manufacturing method of a face pack. It is explanatory drawing of discharge data. It is explanatory drawing of a support body formation process. It is explanatory drawing of an efficacy component liquid discharge process. It is a top view of a face pack. It is a fragmentary sectional view of a face pack. It is a fragmentary sectional view of a face pack in a field where a plurality of kinds of effect ingredient liquids were impregnated in a holder. It is explanatory drawing of the uneven | corrugated shape of the surface of a holding body. It is explanatory drawing of a support body reduction part. It is explanatory drawing of a support body abbreviation part. It is explanatory drawing of a holding body abbreviation part.

  Embodiments of the present invention will be described below with reference to the drawings. Throughout the drawings, the same or equivalent parts and components are denoted by the same or equivalent reference numerals.

  The following embodiments exemplify devices for embodying the technical idea of the present invention, and the technical idea of the present invention is the material, shape, structure, arrangement, etc. of each component. Is not specified as follows. The technical idea of the present invention can be variously modified within the scope of the claims.

  FIG. 1 is a schematic configuration diagram of a face pack manufacturing apparatus (corresponding to a manufacturing apparatus for an active ingredient holding sheet in claims) according to an embodiment of the present invention. FIG. 2 is a schematic configuration diagram of a print engine unit of the face pack manufacturing apparatus shown in FIG. FIG. 3 is a control block diagram of the face pack manufacturing apparatus shown in FIG. In the following description, the direction orthogonal to the paper surface of FIG. 1 is the front-rear direction, and the front surface direction is the front. Also, the top, bottom, left, and right of the paper surface in FIG.

  As shown in FIGS. 1 and 3, the face pack manufacturing apparatus 1 according to the present embodiment includes a measurement unit 2, a print engine unit 3, a print engine moving mechanism unit 4, a supply unit 5, and a transport unit 6. And a receiving unit 7 and a control unit 8. Here, the face pack manufacturing apparatus 1 is applied to a face pack (corresponding to the living body surface of the claim) of a person (corresponding to the living body of the claim) and exerts its effect (on the active ingredient holding sheet of the claim) Device).

  The measurement unit 2 measures the user's face. This measurement is for acquiring user's face information (corresponding to biometric information in claims).

  Here, as shown in FIG. 4, the face information includes face shape information (corresponding to the three-dimensional shape information in the claims), a melamine value, a hemoglobin value, and a skin moisture content.

  The face shape information is information indicating the three-dimensional shape of the user's face. The three-dimensional shape of the face includes the contour of the face, the three-dimensional shape of the entire face formed by the shape and arrangement of each part of the eyes, nose, mouth, cheeks, etc., and unevenness of the skin surface of the face due to wrinkles And shape. The face shape information is acquired as three-dimensional imaging data by three-dimensionally imaging the face with a three-dimensional imaging unit 11 described later.

  The melanin value is information indicating the degree of symptoms of freckles, spots, and hidden spots. The melanin value indicating freckles and spots is acquired by performing color imaging of the face with the 3D imaging unit 11 described later and analyzing the 3D imaging data. Further, the melanin value indicating the hidden stain is acquired by analyzing the three-dimensional imaging data by performing UV (ultraviolet) imaging of the face by the three-dimensional imaging unit 11 described later.

  The hemoglobin value is information indicating the degree of skin redness and acne symptoms. The hemoglobin value is acquired by performing color imaging of the face by the 3D imaging unit 11 described later and analyzing the 3D imaging data.

  The skin moisture content is information indicating the degree of symptom of skin roughness (stickiness). The skin moisture content is acquired by contact measurement on the skin by the skin moisture content measuring unit 12 described later.

  As shown in FIG. 3, the measurement unit 2 includes a three-dimensional imaging unit 11 and a skin moisture content measurement unit 12.

  The three-dimensional imaging unit 11 generates a three-dimensional imaging data by three-dimensionally imaging the user's face. The three-dimensional imaging unit 11 is configured by a three-dimensional imaging device capable of three-dimensional color imaging and UV imaging.

  The skin water content measuring unit 12 measures the skin water content by measuring contact with the skin. The skin moisture content measurement unit 12 is configured by, for example, a Corneometer (registered trademark).

  The print engine unit 3 forms a face pack 61 described later by an ink jet printing method. As shown in FIGS. 2 and 3, the print engine unit 3 includes a base material forming unit 16 and an efficacy component liquid application unit 17.

  The base material forming unit 16 forms a base material 62 of the face pack 61 described later. The substrate forming unit 16 includes a substrate head 21, UV irradiation units 22A and 22B, and drying units 23A and 23B. In addition, the alphabetic suffixes in the reference numerals of the UV irradiation units 22A and 22B, the drying units 23A and 23B, and the like may be omitted and collectively described.

  The substrate head 21 is a droplet discharge head that discharges the support forming liquid and the holding body forming liquid. As the substrate head 21, an inkjet head that ejects ink in an inkjet printing apparatus is used. The substrate head 21 is composed of a multi-drop ink jet head capable of discharging a plurality of droplets per pixel. The substrate head 21 has two nozzle rows (not shown). The substrate head 21 discharges the support forming liquid from the nozzles of one nozzle row, and discharges the holding member forming liquid from the nozzles of the other nozzle row.

  Here, the support forming liquid is a liquid that is a material for forming a support 63 of the base 62 described later. Specifically, the support forming liquid is a liquid of UV curable resin for forming the support 63 made of a liquid impermeable film. The holding body forming liquid is a liquid that is a material for forming the holding body 64 of the base material 62 described later. Specifically, the holding body forming liquid is liquid pulp.

  The UV irradiation unit 22 irradiates the support forming liquid, which is a liquid of UV curable resin, discharged from the base head 21 onto the belt 46 of the transport unit 6 described later, and cures the support forming liquid.

  The UV irradiation units 22A and 22B are arranged to be separated from each other in the front-rear direction with the base material head 21 and efficacy component heads 26A to 26D described later interposed therebetween. Specifically, the UV irradiation unit 22A is disposed on the front side of the substrate head 21, and the UV irradiation unit 22B is disposed on the rear side of the efficacy component head 26D.

  The drying unit 23 dries the holding body forming liquid, which is liquid pulp, discharged from the substrate head 21 to the belt 46 of the transport unit 6 described later by heat. The drying unit 23 is composed of a heater, for example.

  The drying sections 23A and 23B are arranged apart from each other in the front-rear direction with the base material head 21 and efficacy component heads 26A to 26D described later interposed therebetween. Specifically, the drying unit 23A is disposed on the front side of the UV irradiation unit 22A, and the drying unit 23B is disposed on the rear side of the UV irradiation unit 22B. The positional relationship between the drying unit 23A and the UV irradiation unit 22A may be reversed. Further, the positional relationship between the drying unit 23B and the UV irradiation unit 22B may be reversed.

  The efficacy component liquid application unit 17 applies and impregnates the efficacy component liquid to the base material 62. The efficacy component liquid application unit 17 includes efficacy component heads 26A to 26D.

  The efficacy component head 26 is a droplet ejection head that ejects and applies an efficacy component liquid to the substrate 62. The efficacy component heads 26 </ b> A to 26 </ b> D are installed on the rear side of the base material head 21 in parallel in the front-rear direction in the order of the efficacy component heads 26 </ b> A to 26 </ b> D from the front side. The efficacy component heads 26 </ b> A to 26 </ b> D each have two nozzle rows (not shown), like the substrate head 21. The efficacy component heads 26A to 26D eject different types of efficacy component liquids from the nozzle rows. That is, the efficacy component liquid application unit 17 discharges a total of 8 types of efficacy component liquids by the efficacy component heads 26A to 26D. The efficacy component heads 26 </ b> A to 26 </ b> D are multi-drop type inkjet heads as in the case of the substrate head 21.

  The effect ingredient liquid is a liquid in which an effect ingredient having an effect on facial skin is contained in a liquid such as water or oil. Moreover, the efficacy component liquid may contain arbitrary additives, such as antiseptic | preservative, a coloring agent, surfactant, and a fragrance | flavor. Eight kinds of efficacy component liquids discharged from the efficacy component heads 26A to 26D are referred to as first to eighth efficacy component liquids.

  The 1st effect ingredient liquid contains a moisturizing ingredient as an effect ingredient. The moisturizing component is used as an effective component against skin stuffiness. As the moisturizing component, hexanediol, alphahydroxy acid, butylene glycol, dipropylene glycol, ceramide, hyaluronic acid, collagen and the like are used.

  The 2nd effect ingredient liquid contains a dry prevention ingredient as an effect ingredient. The anti-drying component is used as an active ingredient against skin stuffiness. As the anti-drying component, cetanol, cetyl ethylhexanoate, linoleic acid, polyquaterniums and the like are used.

  The third effect ingredient liquid contains a cell activation ingredient as an effect ingredient. The cell activating component is used as an effective component against freckles and spots. As the cell activating component, human oligopeptide, aspartic acid, marine purge, hydrolyzed conchiolin, niacinamide and the like are used.

  The fourth effect component liquid contains a whitening component as an effect component. The whitening component is used as an effective component against stains. Examples of the whitening component include ascorbyl palmitate, nicotinamide, tranexamic acid, ascorbyl tetrahexyldecanoate, arbutin, and placenta.

  The fifth efficacy component liquid contains a peeling component as an efficacy component. The peeling component is used as an effective component against freckles and stains. As the peeling component, alpha hydroxy acid, salicylic acid and the like are used.

  The 6th effect ingredient liquid contains an anti-wrinkle ingredient as an effect ingredient. The anti-wrinkle component is used as an active ingredient against wrinkles on the skin surface. As the anti-wrinkle component, ascorbyl tetrahexyl decanoate, astaxanthin, acetyl hydroxyproline, acetyl hexapeptide and the like are used.

  The seventh effect ingredient liquid contains an ultraviolet ray preventing ingredient as an effect ingredient. The ultraviolet ray preventing component is used as an effective component against hidden stains. As the ultraviolet ray preventing component, ethylhexyl oxycinnamate, oxybenzo, t-butylmethoxydibenzoylmethane and the like are used.

  The eighth efficacy component liquid contains an anti-inflammatory component as an efficacy component. The anti-inflammatory component is used as an effective component against redness and acne in the skin. As the anti-inflammatory component, tranexamic acid, stearyl glycyrrhetinate, nicotinamide or the like is used.

  The first to eighth efficacy component liquids are adjusted in properties such as viscosity so that they can be ejected from the efficacy component head 26. Moreover, you may make it select the kind of inkjet head used as effect component head 26A-26D according to each viscosity etc. of the 1st-8th effect component liquid.

  The print engine moving mechanism unit 4 moves the print engine unit 3 in the front-rear direction. The print engine moving mechanism unit 4 includes a guide unit 31 and a print engine moving motor 32.

  The guide unit 31 is a member that guides the print engine unit 3 to move along the front-rear direction. The print engine moving motor 32 moves the print engine unit 3 in the front-rear direction.

  The supply unit 5 holds the support body forming liquid, the holding body forming liquid, and the first to eighth effect component liquids, and supplies them to the print engine unit 3. As shown in FIGS. 1 and 3, the supply unit 5 includes a support forming liquid tank 36, a support forming liquid supply path 37, a holding body forming liquid tank 38, a holding body forming liquid supply path 39, and an effect. Component liquid tanks 40A to 40H and efficacy component liquid supply paths 41A to 41H are provided.

  The support forming liquid tank 36 stores a support forming liquid. The support body forming liquid supply path 37 is a path for sending the support body forming liquid from the support body forming liquid tank 36 to the substrate head 21.

  The holder forming liquid tank 38 stores the holder forming liquid. The holding body forming liquid supply path 39 is a path for feeding the holding body forming liquid from the holding body forming liquid tank 38 to the substrate head 21.

  The effect ingredient liquid tanks 40A to 40H store the first to eighth effect ingredient liquids, respectively. The efficacy component liquid supply paths 41A to 41H are paths through which the first to eighth efficacy component liquids are fed from the efficacy component liquid tanks 40A to 40H to the efficacy component heads 26A to 26D, respectively.

  The transport unit 6 functions as a forming surface for forming the face pack 61 described later, and transports the formed face pack 61 to the receiving unit 7. The conveyance unit 6 is disposed below the print engine unit 3.

  The transport unit 6 includes a belt 46, a drive roller 47, driven rollers 48 to 50, and a belt drive motor 51.

  The belt 46 constitutes a formation surface 46 a for forming the face pack 61, and conveys the formed face pack 61 to the receiving unit 7.

  The belt 46 is an annular belt that is stretched around the driving roller 47 and the driven rollers 48 to 50. The belt 46 is made of an elastic member such as rubber. The upper surface of the portion that is horizontal between the driving roller 47 and the driven roller 48 of the belt 46 becomes the forming surface 46 a of the face pack 61.

  The drive roller 47 rotates the belt 46 in the clockwise direction in FIG.

  The driven rollers 48 to 50 support the belt 46 together with the driving roller 47. The driven rollers 48 to 50 are driven to rotate by the belt 46. The driven roller 48 has the same height as the drive roller 47 and is disposed on the left side of the drive roller 47. The driven rollers 49 and 50 are spaced apart from each other in the left-right direction at a position lower than the drive roller 47 and the driven roller 48, and are disposed at the same height.

  The belt drive motor 51 rotates the drive roller 47.

  The receiving unit 7 receives the completed face pack 61 conveyed by the conveying unit 6. The receiving unit 7 includes a receiving table 56 and a lifting motor 57.

  The receiving stand 56 is a stand for receiving the completed face pack 61. The receiving table 56 is disposed in the vicinity of the downstream side of the transport unit 6. The receiving stand 56 is configured to be movable up and down.

  The raising / lowering motor 57 raises / lowers the receiving stand 56.

  The control unit 8 controls the operation of the entire face pack manufacturing apparatus 1. The control unit 8 includes a CPU, a RAM, a ROM, a hard disk, and the like.

  Next, a method for manufacturing the face pack 61 by the face pack manufacturing apparatus 1 will be described.

  FIG. 5 is a flowchart of the manufacturing method of the face pack 61 by the face pack manufacturing apparatus 1.

  First, in step S1 of FIG. 5, the control unit 8 executes a face measurement process. The face measurement step is a step of acquiring face information by measuring the face of the user of the face pack 61.

  Specifically, the control unit 8 causes the three-dimensional imaging unit 11 to three-dimensionally image the user's face. At this time, the control unit 8 causes the three-dimensional imaging unit 11 to perform color imaging and UV imaging. The three-dimensional imaging unit 11 generates three-dimensional imaging data based on color imaging and three-dimensional imaging data based on UV imaging, and outputs these to the control unit 8.

  Further, the control unit 8 responds when the operator of the face pack manufacturing apparatus 1 performs an operation of measuring the moisture content at each location while bringing the skin moisture content measurement unit 12 into contact with each location on the user's face. Then, the skin moisture content measured from the skin moisture content measurement unit 12 is acquired. Here, the skin moisture content measured by the skin moisture content measurement unit 12 is acquired as data of the skin moisture content at each location on the face in the three-dimensional imaging data by the three-dimensional imaging unit 11. The data on the amount of skin moisture at each location on the face indicates the distribution of the roughness (stickiness) area on the face and the degree of the symptoms.

  Next, in step S2, the controller 8 executes a discharge data generation process. The discharge data generation step is a step of generating discharge data of the support body forming liquid, the holding body forming liquid, and each efficacy component liquid. The ejection data is data indicating the number of droplets (number of drops) ejected to each pixel in each of the base material head 21 and the efficacy component heads 26A to 26D.

  Specifically, first, the control unit 8 generates face pack shape data based on three-dimensional imaging data by color imaging.

  The face pack shape data is data including a two-dimensional shape of the face pack 61 and a concavo-convex shape on the surface of the face pack 61 that is attached to the face. The face pack shape data is generated by two-dimensionally developing three-dimensional imaging data by color imaging to generate two-dimensional data of the face, and two-dimensional data indicating the uneven shape due to wrinkles on the skin surface in the three-dimensional imaging data by color imaging. Generated in combination with data. Here, the data indicating the uneven shape due to wrinkles on the skin surface in the three-dimensional image data obtained by color imaging indicates the distribution of wrinkle symptoms and the degree thereof (depth of wrinkles).

  The two-dimensional shape of the face pack 61 includes an outer shape of the base material 62 in a plan view and positions and shapes of cut portions 71A to 71E (see FIG. 9) described later. The cut portions 71A to 71E are formed in order to make the base material 62 follow the curved surface of the face.

  Further, the two-dimensional shape of the face pack 61 includes positions and shapes of openings 72A to 72C (see FIG. 9) described later. The openings 72A to 72C are formed in a region where the face pack 61 is not covered on the face. Specifically, the openings 72A to 72C are formed in regions corresponding to the eyes and the mouth.

  Next, the control unit 8 analyzes the three-dimensional imaging data by color imaging and calculates the melanin value at each location on the face. The melanin value of each part of the face obtained by this color imaging indicates the freckles, the distribution of stains, and the degree of their symptoms on the face.

  In addition, the control unit 8 analyzes the three-dimensional imaging data obtained by UV imaging, and calculates the melanin value at each location on the face. The melanin value of each part of the face obtained by this UV imaging indicates the distribution of hidden spots on the face and the degree of symptoms thereof.

  In addition, the control unit 8 analyzes the three-dimensional imaging data by color imaging and calculates the hemoglobin value at each location on the face. The hemoglobin value of each part of the face calculated from the three-dimensional imaging data by color imaging indicates the redness, acne distribution, and the degree of symptoms in the face.

  Next, the control unit 8 maps the melanin value obtained by color imaging, the melanin value obtained by UV imaging, the hemoglobin value, and the skin moisture content at each location on the face to plane coordinates in the face pack shape data.

  Next, the control unit 8 generates discharge data of the support body forming liquid, the holding body forming liquid, and each efficacy component liquid based on the face pack shape data to which the melanin value and the like are mapped.

  Specifically, the control unit 8 stores data in which the number of drops for forming the support 63 made of a film having a predetermined thickness is set at each coordinate forming the two-dimensional shape of the face pack 61. It is generated as ejection data for the forming liquid. In the discharge data of the support body forming liquid, the number of drops at each coordinate corresponding to the cut portion 71 and the opening portion 72 is set to zero.

  In addition, the control unit 8 makes the support member 63 thinner than the other part or forms the holding body 64 so that the base material 62 bends along the face at a portion having a large curvature such as a jaw, but the support body 64 is formed. The ejection data of the support body forming liquid is generated so that a portion in which 63 is omitted is provided. Specifically, the control unit 8 sets the number of drops smaller than the number of drops for forming the support 63 having a predetermined thickness as the number of drops of the support forming liquid in the portion where the support 63 is thinned. To do. Further, the controller 8 sets the number of drops of the support forming liquid to 0 in a portion where the holding body 64 is formed but the support 63 is omitted.

  Further, the control unit 8 generates data in which the number of drops for forming the holding body 64 is set at each coordinate forming the two-dimensional shape of the face pack 61 as discharge data of the holding body forming liquid.

  Here, in the face pack 61, the thickness of the holding body 64 necessary for impregnating the efficacy component liquid is set according to the total number of drops of each efficacy component liquid (total amount of each efficacy component liquid). ing. The greater the total number of drops of each efficacy component liquid, the greater the required thickness of the holder 64. Therefore, the control unit 8 sets the number of drops of the holding body forming liquid at each coordinate so that the thickness of the holding body 64 is adjusted according to the total number of drops of each efficacy component liquid.

  Further, the control unit 8 sets the number of drops at each coordinate so that the uneven shape on the surface of the holding body 64 attached to the face becomes a shape corresponding to the uneven shape due to wrinkles on the skin surface. For example, the control unit 8 sets the number of drops of each coordinate of the portion so that the holding body 64 is formed with a convex portion corresponding to the depth corresponding to the portion where the skin is recessed due to wrinkles.

  Also, in the discharge data of the holding body forming liquid, the number of drops at each coordinate corresponding to the cut portion 71 and the opening 72 is set to 0, similarly to the discharge data of the support forming liquid.

  In addition, the control unit 8 discharges the holding body forming liquid so that the base member 62 is bent along the curved surface of the face so that the support body 63 is formed but the holding body 64 is omitted. Is generated. Specifically, the controller 8 sets the number of drops of the holding body forming liquid to 0 in the portion where the support body 63 is formed but the holding body 64 is omitted.

  Moreover, the control part 8 sets the number of drops of each efficacy component liquid based on values, such as a melanin value in each coordinate, and produces | generates the discharge data of each efficacy component liquid.

  Specifically, the control unit 8 determines that the region where the melanin value obtained by color imaging is equal to or greater than the threshold is a region with freckles or spots. And the control part 8 sets the number of drops of at least any one of the 3rd-5th effect component liquid with respect to each coordinate of the area | region where the melanin value obtained by color imaging is more than a threshold value. The number of drops is a value corresponding to the size of the melanin value obtained by color imaging at each coordinate.

  In addition, the control unit 8 determines that a region where the melanin value obtained by UV imaging is equal to or greater than the threshold is a region where there is a hidden spot symptom. And the control part 8 is the number of drops of the 7th effect component liquid according to the magnitude | size of the melanin value obtained by UV imaging with respect to each coordinate of the area | region where the melanin value obtained by UV imaging is more than a threshold value Set.

  In addition, the control unit 8 determines that the region where the hemoglobin value is equal to or greater than the threshold is a region with redness or acne symptoms. And the control part 8 sets the number of drops of the 8th effect component liquid according to the magnitude | size of a hemoglobin value with respect to each coordinate of the area | region where a hemoglobin value is more than a threshold value.

  Moreover, the control part 8 judges that the area | region where the amount of skin moisture is less than a threshold value is an area | region with the symptom of stuffiness. And the control part 8 sets the number of drops of at least one of the 1st and 2nd effect ingredient liquid with respect to each coordinate of the area | region where the amount of skin moisture is less than a threshold value. The number of drops is a value according to the amount of skin moisture.

  Moreover, the control part 8 sets the number of drops of the 6th effect ingredient liquid according to the depth of a wrinkle with respect to each coordinate of the field in which the concavo-convex shape by the wrinkle on the skin surface is formed.

  As described above, the discharge data of the support body forming liquid, the holding body forming liquid, and the discharge data of each efficacy component liquid as shown in FIG. 6 is generated. Here, each coordinate in the ejection data corresponds to a pixel at the time of printing by the substrate head 21 and the effect component heads 26A to 26D.

  By the way, since there are regions where a plurality of symptoms are overlapped on the face, a plurality of types of efficacy component liquids are ejected with respect to the same coordinate (same region) in the ejection data of each efficacy component liquid. The number of drops may be set. In this case, the control unit 8 sets the discharge order of a plurality of types of efficacy component liquids for the same coordinates.

  Specifically, the control unit 8 sets the discharge order so that the higher-priority efficacy component liquid is discharged later. The priority of the active ingredient liquid is higher as the degree of the corresponding symptom is larger. When the degree of the symptom is similar, the control unit 8 sets the ejection order based on the priority set in advance for each symptom or the priority specified by the user. In addition, you may set the priority of an active ingredient liquid from a viewpoint of the permeability | transmittance of an active ingredient to the skin. When a plurality of types of efficacy component liquids are ejected with respect to the same coordinates, the later-emitted efficacy component liquids are attached to the face of the holding body 64 in the thickness direction of the holding body 64 (base material 62). Located near the side surface.

  Next, in step S3 of FIG. 5, the control unit 8 executes a support forming process.

  Specifically, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 in the front-rear direction, and forms the conveyance unit 6 from the substrate head 21 based on the discharge data of the support forming liquid. Printing for one pass is performed by discharging the support forming liquid onto the surface 46a. At this time, the control unit 8 cures the support forming liquid by irradiating the support forming liquid discharged onto the forming surface 46 a with ultraviolet rays from the UV irradiation unit 22. Next, the control unit 8 controls the belt drive motor 51 to send the belt 46 rightward by the print width of one pass.

  The controller 8 forms the support 63 as shown in FIG. 7 by alternately repeating the printing for one pass and the curing of the support forming liquid and the feeding operation of the belt 46.

  Here, when the support body forming liquid is discharged from the substrate head 21 while moving the print engine section 3 from the front side to the rear side, the control section 8 immediately supports the support body forming liquid discharged on the forming surface 46a. The support forming liquid is cured by irradiating ultraviolet rays from the UV irradiator 22A. Further, when discharging the support forming liquid from the substrate head 21 while moving the print engine unit 3 from the rear side to the front side, the control unit 8 applies the support forming liquid immediately after being discharged onto the forming surface 46a. The support forming liquid is cured by irradiating with ultraviolet rays from the UV irradiation unit 22B.

  Next, in step S4 of FIG. 5, the control unit 8 executes a holding body forming process.

  Specifically, first, the control unit 8 controls the belt drive motor 51 to send the belt 46 leftward to return the support 63 to a predetermined position.

  Thereafter, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 in the front-rear direction, while forming the holding body from the substrate head 21 to the support 63 based on the discharge data of the holding body forming liquid. By discharging the liquid, printing for one pass is performed. At this time, the control unit 8 causes the drying unit 23 to dry the holding body forming liquid discharged onto the support 63. Next, the control unit 8 controls the belt drive motor 51 to send the belt 46 rightward by the print width of one pass.

  The control unit 8 alternately stacks the printing for one pass and the drying of the holding body forming liquid and the feeding operation of the belt 46 to form the holding body 64 by being stacked on the support body 63. Thereby, the base material 62 which has the support body 63 and the holding body 64 is formed on the formation surface 46a. The holding body 64 is made of pulp formed by drying liquid pulp, and has a structure capable of impregnating the efficacy component liquid by allowing the efficacy component liquid to permeate into the gaps between the fibers.

  Next, in step S5, the control unit 8 executes an efficacy component liquid application step.

  Specifically, first, the control unit 8 controls the belt drive motor 51 to send the belt 46 leftward to return the base material 62 to a predetermined position.

  Thereafter, the control unit 8 controls the print engine moving motor 32 to move the print engine unit 3 in the front-rear direction, while holding the base material 62 from each efficacy component head 26 based on the ejection data of each efficacy component liquid. 64, each effect ingredient liquid is discharged. The active ingredient liquid discharged to the holding body 64 penetrates and is impregnated into the holding body 64.

  Here, when there are regions for discharging a plurality of types of efficacy component liquids for the same pixel (same coordinates), the ejection order of each efficacy component liquid is set as described above. On the other hand, since the positional relationship in the front-rear direction of each efficacy component head 26 that ejects each efficacy component liquid is fixed, the set ejection order may not be realized by a single printing operation for one pass. is there. Therefore, when there is a region for ejecting a plurality of types of efficacy component liquids for the same pixel, the control unit 8 performs a printing operation by moving the print engine unit 3 from the front side to the rear side and a movement from the rear side to the front side. In combination with the printing operation, the set ejection order of each of the efficacy component liquids is realized.

  When the discharge based on the discharge data of each active ingredient liquid for the area corresponding to the printing width of one pass is completed, the control unit 8 controls the belt driving motor 51 to send the belt 46 rightward by the printing width of one pass. .

  As shown in FIG. 8, the control unit 8 alternately repeats the discharge of each effective component liquid to the region corresponding to the printing width of one pass and the feeding operation of the belt 46, so that the respective effects on the base material 62 are as shown in FIG. 8. The component liquid is discharged. When the discharge of each active ingredient liquid to the discharge target area of the entire base material 62 is finished, the manufacture of the face pack 61 is finished.

  When the manufacture of the face pack 61 is completed, the control unit 8 controls the transport unit 6 to send the completed face pack 61 toward the receiving table 56. Then, the control unit 8 controls the receiving unit 7 to receive the face pack 61 from the transport unit 6 while lowering the receiving table 56.

  Next, the face pack 61 manufactured by the above-described face pack manufacturing apparatus 1 will be described.

  FIG. 9 is a plan view of the face pack 61. FIG. 10 is a partial cross-sectional view of the face pack 61.

  As shown in FIGS. 9 and 10, the face pack 61 includes a sheet-like base material 62. The base material 62 includes a support body 63 and a holding body 64.

  The support body 63 supports the holding body 64. The support 63 is formed of a sheet-like liquid-impermeable film.

  The holding body 64 holds an active ingredient liquid according to the user's face information. As described above, the holding body 64 is made of pulp formed by drying liquid pulp, and has a structure that allows the liquid to be impregnated by the penetration of the active ingredient liquid into the gaps between the fibers. The holding body 64 is formed by being laminated on the support body 63.

  The external shape of the base material 62 of the face pack 61 in a plan view is formed into a shape obtained by two-dimensionally developing three-dimensional imaging data of the user's face. Moreover, as shown in FIG. 9, the base material 62 of the face pack 61 is provided with cut portions 71A to 71E and openings 72A to 72C.

  The cut portions 71A to 71D are cuts for causing the face pack 61 (base material 62) to follow the facial contour. The cut portion 71E is a cut for causing the face pack 61 (base material 62) to follow the nose. The cut portions 71A to 71E are formed by determining the arrangement and shape based on the user's face shape information (three-dimensional imaging data).

  The openings 72A to 72C are for avoiding the covering of the face pack 61 (base material 62) on the left eye, the right eye, and the mouth, respectively. The openings 72A to 72C are formed by determining the arrangement and shape based on the user's face shape information (three-dimensional imaging data).

  Further, the holding body 64 of the base material 62 of the face pack 61 is impregnated with a kind of effect ingredient liquid according to the face information.

  For example, in the areas 73 </ b> A to 73 </ b> L shown in FIG. 9, the efficacy component liquid corresponding to the symptoms in the areas on the user's face corresponding to each of the areas is impregnated. Here, the region 73A, the regions 73B to 73E, the regions 73F and 73G, the regions 73H to 73J, and the regions 73K and 73L are regions corresponding to different symptoms. However, a plurality of symptoms may overlap in at least a part of the area on the face corresponding to each area 73. For this reason, in each area | region 73, at least one part of the said area | region 73 may be an area | region where several types of effect component liquid was impregnated in the same area | region.

  As described above, since the regions 73A to 73L include a plurality of regions impregnated with efficacy component liquids corresponding to different symptoms, the base material 62 is impregnated with different types of efficacy component liquids. There are multiple areas. For example, as shown in FIG. 10, the holding body 64 includes a region impregnated with the efficacy component liquid 76A and a region impregnated with a different kind of efficacy component liquid 76B from the efficacy component liquid 76A. Here, each of the efficacy component liquids 76A and 76B is any one of the first to eighth efficacy component liquids.

  In addition, as described above, when there is a region where a plurality of symptoms are overlapped on the face, the holding body 64 has a region where a plurality of types of efficacy component liquids are impregnated in the same region in plan view. There is. For example, as shown in FIG. 11, the holding body 64 may have a region in which different types of efficacy component liquids 76 </ b> C and 76 </ b> D are impregnated in the same region. In the example of FIG. 11, of the efficacy component liquids 76 </ b> C and 76 </ b> D, the efficacy component liquid 76 </ b> C disposed near the surface of the holder 64 attached to the face has higher priority in this region. is there. Here, each of the efficacy component liquids 76C and 76D is any one of the first to eighth efficacy component liquids.

  It should be noted that all of the regions 73 impregnated with the efficacy component liquid in the holding body 64 may be impregnated with a plurality of types of efficacy component liquids throughout the region 73.

  In addition, the amount of each effective ingredient liquid impregnated in the face pack 61 holder 64 is adjusted according to the degree of the corresponding symptoms.

  Further, in the face pack 61, the thickness of the holding body 64 in each region impregnated with the efficacy component liquid is the amount of the efficacy component liquid to be impregnated (in the case where a plurality of types of efficacy component liquids are impregnated, the total amount thereof). Accordingly, the thickness is adjusted to be more than necessary for impregnating the efficacy component liquid.

  Moreover, in the face pack 61, the uneven | corrugated shape according to the uneven | corrugated shape by the wrinkle of a user's skin surface is formed in the surface of the side stuck on the face of the holding body 64. FIG. For example, as shown in FIG. 12, in the holding body 64, convex portions 64a corresponding to concave portions due to wrinkles on the skin surface of the user are formed. In FIG. 12, the holding body 64 is impregnated with the efficacy component liquid 76 that is one of the first to eighth efficacy component liquids. The same applies to FIGS. 13 to 15 described later.

  Further, the face pack 61 is provided with a support reduction part 63a as shown in FIG. 13, which is formed so that the base material 62 bends along the face at a portion where the curvature of the face is large. The support body reduction | decrease part 63a is a part which made the support body 63 thinner than another part.

  Further, in the face pack 61, the base material 62 is formed so as to bend along the face at a portion where the curvature of the face is large, and as shown in FIG. Such a holder omission part 64b is provided. The support omitted portion 63b is a portion where the support 63 is omitted although the holding member 64 is provided. The holding body omitted portion 64b is a portion where the holding body 64 is omitted although the support 63 is provided.

  The support body reduction part 63a, the support body omission part 63b, and the holding body omission part 64b are formed at appropriate positions according to the three-dimensional shape of the user's face.

  The face pack 61 configured as described above is affixed to the user's face so that the holding body 64 contacts the user's face. Thereby, each efficacy component liquid impregnated in the holding body 64 comes into contact with the skin of the user's face and exhibits efficacy.

  As described above, in the face pack manufacturing apparatus 1 of the present embodiment, the active ingredient liquid application unit 17 applies and impregnates the active ingredient liquid according to the user's face information to the holding body 64 of the base material 62. . Thereby, since the face pack 61 which hold | maintained the efficacy component liquid according to the skin symptom in a user's face can be provided, the effect with respect to a user's face can be improved.

  Specifically, in the face pack manufacturing apparatus 1, the base material 62 is impregnated with a type of efficacy component liquid corresponding to the symptom of each region for each region corresponding to the symptom of the face. Thereby, since the efficacy component liquid suitable for a symptom can be supplied for every facial area | region, the efficacy with respect to a user's face can be improved.

  Moreover, in the face pack manufacturing apparatus 1, since the amount of the active ingredient liquid is adjusted according to the degree of facial symptoms, the effect on the user's face can be further enhanced.

  Moreover, in the face pack manufacturing apparatus 1, when impregnating a plurality of types of effect component liquids in the same region, the higher priority effect component liquids are arranged closer to the surface of the base 62 on the side to be attached to the face. In this manner, the holder 64 of the base material 62 is impregnated with each of the efficacy component liquids. Specifically, in the face pack manufacturing apparatus 1, when a plurality of types of efficacy component liquids are impregnated in the same region, the efficacy component liquids with higher priority are discharged to the holding body 64 later. Thereby, in the area | region where several types of efficacy component liquid was impregnated in the same area | region, the effect of each efficacy component liquid can be exhibited efficiently according to a priority.

  Further, in the face pack manufacturing apparatus 1, the thickness of the holding body 64 in each region is adjusted according to the amount of the effective component liquid in each region impregnated with the effective component liquid. Thereby, the holding | maintenance state of the active ingredient liquid in the face pack 61 can be kept favorable.

  In the face pack manufacturing apparatus 1, the base material 62 is formed by the base material forming unit 16. For this reason, the face pack 61 can be manufactured without preparing the base material 62 separately.

  Moreover, in the face pack manufacturing apparatus 1, the cut part 71 and the opening part 72 are formed based on a user's face shape information. Thereby, according to curvature of a user's face, and positions, such as eyes and a nose, cut part 71 and opening 72 can be formed in a suitable shape in a suitable position. As a result, the face pack 61 can have a shape corresponding to the actual face shape of the user with high accuracy.

  Moreover, in the face pack manufacturing apparatus 1, the uneven | corrugated shape according to the uneven | corrugated shape of a user's skin surface is formed in the surface of the side affixed on the face of the holding body 64 based on a user's face shape information. Thereby, since it becomes possible to contact an effect ingredient liquid also to the wrinkled part of a user's face, the effect with respect to a user's face can be improved more.

  Further, in the face pack manufacturing apparatus 1, the base material 62 is formed by forming the sheet-like support 63 and laminating the support 64 on the support 63. Thereby, since the support body 63 supports the holding body 64, the shape of the face pack 61 can be prevented from being lost.

  Moreover, in the face pack manufacturing apparatus 1, since the support body 63 is formed of a liquid-impermeable film, evaporation and outflow of the active ingredient liquid held by the holding body 64 can be suppressed, and the holding body 64 allows the active ingredient liquid to be used for a long time. Can hold.

  Moreover, in the face pack manufacturing apparatus 1, the part (support body reduction part 63a) which made the support body 63 thinner than another part is formed so that the base material 62 may bend along a face. Thereby, the face pack 61 can be more closely attached to the face.

  Further, in the face pack manufacturing apparatus 1, portions where the support body 63 or the holding body 64 are omitted from the base material 62 (support body omission part 63b, holding body omission part 64b) are provided so that the base material 62 bends along the face. Forming. Thereby, the face pack 61 can be more closely attached to the face.

  Further, in the face pack manufacturing apparatus 1, the substrate 62 is formed by discharging the support forming liquid and the holding body forming liquid by the substrate head 21 which is an ink jet head (droplet discharge head). Thereby, the base material 62 can be formed easily. Moreover, the notch part 71 and the opening part 72 can be formed in the base material 62, without performing a cutting process. Furthermore, a portion where the support 63 is thinned (support reduction portion 63a) and a portion where the support 63 or the holding body 64 is omitted (support omitted portion 63b, holding member omitted portion 64b) can be easily formed.

  Further, in the face pack manufacturing apparatus 1, the efficacy component liquid is ejected by the efficacy component head 26 which is an ink jet head (droplet ejection head), and the base material 62 is impregnated. Thereby, an effect ingredient liquid can be easily given to substrate 62. Further, the application amount and application position of the efficacy component liquid to the base material 62 can be finely adjusted.

[Other embodiments]
Although the embodiment has been described as described above, it should not be understood that the description and drawings constituting a part of this disclosure limit the present invention. From this disclosure, various alternative embodiments, examples and operational techniques will be apparent to those skilled in the art.

  In the above-described embodiment, the base pack 62 is formed in the face pack manufacturing apparatus 1, and the face pack 61 is manufactured by applying the active ingredient liquid to the formed base base 62. However, the face pack may be manufactured by applying and impregnating a separately prepared base material with an active ingredient liquid according to face information by the face pack manufacturing apparatus 1.

  In the embodiment described above, the melamine value, hemoglobin value, skin moisture amount, and uneven shape due to wrinkles on the skin surface are used as information indicating the symptoms on the face included in the face information, but some of these are omitted. Alternatively, measurement values corresponding to other symptoms may be employed.

  In the above-described embodiment, the base material 62 of the face pack 61 is impregnated with a plurality of types of active ingredient liquids. However, depending on the symptoms of the user's face, the base material 62 may be impregnated with one type of active ingredient liquid. There is.

  In the above-described embodiment, the face pack 61 is manufactured using the facial information obtained by measuring the user's face with the measurement unit 2 of the face pack manufacturing apparatus 1. However, facial information may be acquired from an external device. Further, the operator of the face pack manufacturing apparatus 1 may input face information by operating an operation input unit (not shown). Moreover, the control part 8 may memorize | store the user's past face information, and the face pack 61 may be manufactured using the face information.

  In the embodiment described above, the base material 62 is formed by discharging the support body forming liquid and the holding body forming liquid with the base material head 21 which is an ink jet head. Further, the efficacy component liquid was discharged onto the substrate 62 by the efficacy component head 26 which is an inkjet head. However, the present invention is not limited to the ink jet head, and for example, at least one of a support forming liquid, a holding body forming liquid, and an efficacy component liquid may be discharged by a dispenser. In addition, as long as it is a means capable of discharging or ejecting liquid, a spray, a syringe, or a sputum may be used, or a pump or a motor may be used. Further, for example, in the case where the viscosity of the liquid is high, a contact-type separating means may be provided in order to separate the liquid from the discharge port or the injection port.

  In the embodiment described above, the base material 21 is formed using an inkjet head, but using means such as heat melting, photocuring phenomenon, adhesive, laser irradiation, cutting plotter, etc. used in a 3D printer, You may make it form a base material.

  In the above-described embodiment, a multi-drop inkjet head is used, but a binary inkjet head may be used.

  In the above-described embodiment, the base material is formed and the active ingredient liquid is applied by the multi-pass method (serial method). However, the single-pass method (line method) may be used.

  In the above-described embodiment, UV imaging is performed for acquiring biological information (face information). However, imaging using infrared rays, microwaves, two-photon excitation fluorescence, and invisible light may be performed.

  In the embodiment described above, the support 63 is made of a film made of a UV curable resin, but may be made of another material. In the embodiment described above, the holding body 64 is formed by drying the liquid pulp. However, the holding body 64 may be formed of another material such as a porous material that can be impregnated with liquid.

  In the embodiment described above, the base material 62 has the support 63 and the holding body 64, but the whole base material may be made of a holding body that can be impregnated with a liquid.

  In the above-described embodiment, a portion where the support 63 is thinned on the base material 62 (support reduction portion 63a), and a portion where the support 63 or the holding body 64 is omitted (support omitting portion 63b, holding body omitting portion). 64b) was formed. However, any of these may be omitted according to the shape of the user's face.

  In the above-described embodiment, after the formation of the support body 63 is completed, the holding body 64 is formed and the base material 62 is completed, and then the active ingredient liquid is applied to the base material 62. However, the face pack 61 is manufactured by forming the support 63, forming the holding body 64, and applying the active ingredient liquid to the base material 62 for each printing width of one pass by the print engine unit 3. Also good.

  You may form the base material 62 so that the one part may overlap with another part. For example, a part of the part covering the nose in the base material 62 may overlap with the peripheral part.

  In the embodiment described above, based on the user's face information, the base material head 21 forms the support 63 and the holding body 64 to form the base material 62, and the efficacy component head 26 applies the efficacy component liquid to the base material 62. The face pack 61 was manufactured by discharging. However, the face pack may be manufactured using the base material head 21 and the efficacy component head 26 without using the user's face information. In this case, for example, a base material having a predetermined standard shape is formed using the base material head 21. Then, at least one kind of effect component liquid designated in advance is discharged from at least one of the effect component heads 26A to 26D onto the base material to manufacture the face pack. Further, a face pack may be manufactured by discharging at least one kind of pre-designated efficacy component liquid from at least one of the efficacy component heads 26A to 26D to the base material prepared in advance. .

  In this case, a plurality of types of previously-designated efficacy component liquids are discharged to the designated areas so that a plurality of regions impregnated with different types of efficacy component liquids are formed on the substrate. The substrate may be impregnated. Thereby, since different efficacy component liquids can be set for each area of the face, it is possible to provide an efficacy ingredient liquid that is assumed to be suitable for each area and to enhance the efficacy on the user's face.

  In the above-described embodiment, the case where the face pack covers the entire face has been described. However, the face pack may cover a part of the face.

  In the embodiment described above, the case where the active ingredient holding sheet is a face pack has been described, but the active ingredient holding sheet is not limited to the face pack. For example, the active ingredient holding sheet may be a medical sheet attached to a patient.

  The medical sheet is obtained by impregnating a sheet-like base material similar to the base material 62 in the above-described embodiment with an efficacy component liquid containing a medical efficacy ingredient.

  Examples of the active ingredient for medical use include NSAIDs (non-steroidal anti-inflammatory analgesics) such as diclofenac sodium and indomethacin as effective ingredients for symptoms such as sprains and muscle pain. In addition, there are bronchodilators, anti-inflammatory analgesics and the like as active ingredients for symptoms such as cough and asthma. In addition, there are antiallergic agents such as steroids and antihistamines as active ingredients for symptoms such as urticaria, itching and dermatitis. In addition, there are antibacterial agents, antibiotics, and the like as active ingredients for symptoms such as trauma, ringworm (athlete's foot), and jumpiness. Moreover, there exist antiviral agents etc. as an active ingredient with respect to herpes virus etc.

  The medical sheet manufacturing apparatus has the same configuration as the face pack manufacturing apparatus 1 of the above-described embodiment. However, the skin water content measuring unit 12 of the measuring unit 2 is replaced with a measuring instrument for measuring the symptoms of the patient. In addition, as the efficacy component liquid ejected by the efficacy component head 26, those containing the above-mentioned efficacy components for medical use are used. The medical sheet is manufactured in such a manufacturing apparatus in the same process as the face pack 61 of the above-described embodiment.

  Here, the application target area of the face pack 61 of the above-described embodiment is the face of the user, whereas the application target area of the medical sheet is an area corresponding to a patient's symptom. Depending on the three-dimensional shape of the application target region of the medical sheet, at least one of the cut portion and the opening portion of the base material may be unnecessary. For this reason, at least one of the notch | incision part and opening part of a base material may be abbreviate | omitted. Similarly, at least one of a part where the support is thinned (support reduction part) and a part where the support or the holding body is omitted (support omitted part, holding part omitted part) may be omitted.

  In addition, depending on the surface shape of the application target region of the medical sheet and the symptoms of the patient, the uneven shape of the substrate surface corresponding to the uneven shape due to skin wrinkles may be unnecessary. For this reason, it may be omitted to form a concavo-convex shape on the surface of the base material to be attached to the patient.

  Moreover, when manufacturing a medical sheet | seat, the operator of the medical sheet manufacturing apparatus may be made to input into a manufacturing apparatus based on a doctor's etc. diagnosis. In this case, in the medical sheet manufacturing apparatus, a measuring instrument for measuring a patient's symptoms may be omitted.

  Although the face pack which is an active ingredient holding sheet in the embodiment described above is attached to a person, the active ingredient holding sheet may be attached to a living body such as an animal other than a human being or a plant. Good. For example, the medical sheet described above may be for animals.

  Further, the active ingredient holding sheet may be a plant sheet to be attached to a plant. The plant sheet is obtained by impregnating a sheet-like base material similar to the base material 62 in the above-described embodiment with an effect ingredient liquid containing an effect ingredient for plants.

  One type of plant-use active ingredient is a benzimidazole-based fungicide such as thiophanate methyl. This active ingredient is for promoting the healing of plant cuts and wounds. In other words, this active ingredient prevents the invasion of pathogenic bacteria, cuts off the wounds after cutting the pruning and branching of the plant, and the wounds after the diseased part has been scraped off, and prevents healing of the cuts and wounds. is there.

  The plant sheet manufacturing apparatus has the same configuration as the face pack manufacturing apparatus 1 of the above-described embodiment. However, the skin moisture content measuring unit 12 of the measuring unit 2 is replaced with a measuring instrument for measuring the symptoms of the plant. Moreover, as an effect ingredient liquid which the effect ingredient head 26 discharges, what contains the above-mentioned effect ingredient for plants is used. The plant sheet is manufactured in such a manufacturing apparatus in the same process as the face pack 61 of the above-described embodiment.

  Here, the application target area of the face pack 61 of the above-described embodiment is the face of the user, whereas the application target area of the plant sheet is an area corresponding to a symptom of a plant. Depending on the three-dimensional shape of the application target region of the plant sheet, at least one of the cut portion and the opening portion of the base material may be unnecessary. For this reason, at least one of the notch | incision part and opening part of a base material may be abbreviate | omitted. Similarly, at least one of a part where the support is thinned (support reduction part) and a part where the support or the holding body is omitted (support omitted part, holding part omitted part) may be omitted.

  Moreover, the uneven | corrugated shape of the base-material surface according to the uneven | corrugated shape of a plant surface may be unnecessary depending on the surface shape of the sticking target area | region of a plant sheet, and the symptom of a plant. For this reason, it may be omitted to form an uneven shape on the surface of the substrate that is attached to the plant.

  Moreover, when manufacturing the sheet | seat for plants, the operator of the manufacturing apparatus of a plant sheet | seat may input into the manufacturing apparatus the symptom of a plant. In this case, the measuring device for measuring the symptom of the plant may be omitted in the plant sheet manufacturing apparatus.

  Moreover, you may make it apply | coat the powdery chemical | medical agent containing an active ingredient with respect to the base material of an active ingredient holding sheet, such as a face pack impregnated with the active ingredient liquid. In this case, the device for producing an active ingredient-holding sheet includes a drug application unit for applying a powdered drug containing the active ingredient to a substrate, and the drug application unit applies the powdered drug to the substrate. You may make it apply | coat to. Thereby, it becomes possible to manufacture an active ingredient holding sheet using a powdery medicine. In addition, the powdery medicine apply | coated to a base material may contain the component which improves the fixability to the base material of an effect ingredient liquid.

  As described above, the present invention naturally includes various embodiments not described herein. Therefore, the technical scope of the present invention is defined only by the invention specifying matters according to the scope of claims reasonable from the above description.

[Appendix]
The present application discloses the following inventions.

(Appendix 1)
A method for producing an active ingredient holding sheet to be attached to a living body,
The manufacturing method of the active ingredient holding sheet | seat characterized by including the process of impregnating the active ingredient liquid according to biometric information with respect to a sheet-like base material.

(Appendix 2)
The step of impregnating the efficacy component liquid is a step of discharging the efficacy component liquid onto the base material by a droplet ejection head and impregnating the base material with the efficacy component liquid. A method for producing an active ingredient-holding sheet.

(Appendix 3)
The method for producing an efficacy component holding sheet according to supplementary note 1 or 2, further comprising a step of forming the substrate.

(Appendix 4)
The step of forming the substrate comprises
The production of the active ingredient holding sheet according to appendix 3, wherein the base material is formed by discharging a liquid, which is a material of the base material, onto a forming surface of the active ingredient holding sheet by a droplet discharge head. Method.

(Appendix 5)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The effect ingredient according to appendix 3 or 4, wherein, in the step of forming the base material, a notch for forming the base material along the surface of the living body is formed on the base material based on the three-dimensional shape information. Manufacturing method of holding sheet.

(Appendix 6)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The effect according to any one of appendices 3 to 5, wherein, in the step of forming the base material, an opening is formed in a region where the base material is not covered with the living body based on the three-dimensional shape information. A method for producing an ingredient holding sheet.

(Appendix 7)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
In the step of forming the base material, an uneven shape corresponding to the uneven shape of the surface of the living body is formed on the surface of the base material that is attached to the living body based on the three-dimensional shape information. The manufacturing method of the active ingredient holding sheet in any one of 3 thru | or 6.

(Appendix 8)
The base material has a holding body impregnated with an efficacy component liquid, and a support body that supports the holding body,
The step of forming the substrate comprises
Forming the sheet-like support;
The method for producing an effect ingredient-holding sheet according to any one of appendices 3 to 7, further comprising a step of forming the holding body by laminating the support.

(Appendix 9)
The method for producing an efficacy component holding sheet according to appendix 8, wherein the step of forming the support is a step of forming the support by a liquid-impermeable film.

(Appendix 10)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
Supplementary note 8: In the step of forming the support, a portion where the support is thinner than other portions is provided so that the base material bends along the surface of the living body based on the three-dimensional shape information. Or the manufacturing method of the active ingredient holding sheet of 9.

(Appendix 11)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
In the step of forming the base material, a portion in which the support body or the holding body is omitted is provided on the base material so that the base material bends along the living body surface based on the three-dimensional shape information. The manufacturing method of the efficacy component holding sheet in any one of the additional notes 8 thru | or 10.

(Appendix 12)
The biological information includes information indicating a distribution for each symptom on a biological surface to which the active ingredient holding sheet is applied,
Supplementary note 1 wherein, in the step of impregnating the efficacy component liquid, the base material is impregnated with a kind of efficacy component liquid corresponding to the symptom for each region according to the symptom on the surface of the living body based on the biological information. The manufacturing method of the active ingredient holding sheet in any one of thru | or 11.

(Appendix 13)
The biological information includes information indicating the degree of symptoms on the surface of the biological target to which the active ingredient holding sheet is applied,
The method for producing an efficacy component holding sheet according to appendix 12, wherein in the step of impregnating the efficacy component solution, the amount of each efficacy component solution is adjusted according to the degree of symptoms on the surface of the living body.

(Appendix 14)
The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
The entire base material is composed of a holder that can be impregnated with an effect ingredient liquid,
In the step of impregnating the efficacy component liquid, the base material is impregnated with an amount of the efficacy component liquid according to the symptom in an amount corresponding to the symptom for each region according to the symptom of the living body based on the biological information. Process,
In the step of forming the base material, the thickness of the base material in each region is adjusted according to the amount of the active ingredient liquid impregnated in each region. A method for producing an active ingredient-holding sheet.

(Appendix 15)
The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
In the step of impregnating the efficacy component liquid, the base material is impregnated with an amount of the efficacy component liquid according to the symptom in an amount corresponding to the symptom for each region according to the symptom of the living body based on the biological information. Process,
12. The method according to any one of appendices 8 to 11, wherein in the step of forming the holding body, the thickness of the holding body in each region is adjusted according to the amount of the active ingredient liquid impregnated in each region. A method for producing an active ingredient-holding sheet.

(Appendix 16)
In the step of impregnating the efficacy component liquid, in the case where a plurality of types of efficacy component liquids are impregnated in the same region, the higher priority efficacy component liquid is attached to the base body in the thickness direction of the base material. The method for producing an active ingredient-holding sheet according to any one of appendices 12 to 15, wherein the base material is impregnated with each of the active ingredient liquids so as to be disposed near the surface on the side to be provided.

(Appendix 17)
A method for producing an active ingredient holding sheet to be attached to a living body,
The manufacturing method of an active ingredient holding sheet | seat characterized by including the process of impregnating a mutually different area | region with multiple types of active ingredient liquid with respect to a sheet-like base material.

(Appendix 18)
18. The method for producing an efficacy component holding sheet according to any one of appendices 1 to 17, further comprising a step of applying a powdered drug containing the efficacy component to a base material impregnated with the efficacy component liquid.

(Appendix 19)
A device for producing an active ingredient holding sheet to be attached to a living body,
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid imparting section that imparts and impregnates an efficacy component liquid according to biological information to a sheet-like base material.

(Appendix 20)
The apparatus for producing an efficacy component holding sheet according to appendix 19, wherein the efficacy component liquid application unit is configured to eject and apply the efficacy component liquid to the substrate with a droplet ejection head.

(Appendix 21)
The apparatus for producing an effect ingredient-holding sheet according to Supplementary Note 19 or 20, further comprising a base material forming part for forming the base material.

(Appendix 22)
The supplementary note 21 is characterized in that the base material forming unit is configured to eject a liquid, which is a material of the base material, onto a forming surface of the active ingredient holding sheet by a droplet discharge head to form the base material. The manufacturing apparatus of the active ingredient holding sheet of description.

(Appendix 23)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The said base material formation part forms the cut | notch part for making the said base material along a biological body surface based on the said three-dimensional shape information in the said base material, The active ingredient holding of Additional remark 21 or 22 characterized by the above-mentioned Sheet manufacturing equipment.

(Appendix 24)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
24. The active ingredient holding according to any one of appendices 21 to 23, wherein the base material forming portion forms an opening in a region where the base material is not covered with the living body based on the three-dimensional shape information. Sheet manufacturing equipment.

(Appendix 25)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The base material forming unit forms a concavo-convex shape according to the concavo-convex shape of the surface of the living body on the surface of the base material to be attached to the living body based on the three-dimensional shape information. The manufacturing apparatus of the active ingredient holding sheet in any one of 24.

(Appendix 26)
The base material has a holding body impregnated with an efficacy component liquid, and a support body that supports the holding body,
The substrate forming part is
The active ingredient holding according to any one of appendices 21 to 25, wherein the base material is formed by forming the sheet-like support and laminating the support to form the holding body. Sheet manufacturing equipment.

(Appendix 27)
27. The device for producing an active ingredient-holding sheet according to appendix 26, wherein the base material forming unit forms the support with a liquid-impermeable film.

(Appendix 28)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
Supplementary note 26 or 27, wherein the base material forming portion is provided with a portion where the support body is thinner than other portions so that the base material bends along the surface of the living body based on the three-dimensional shape information. The manufacturing apparatus of the active ingredient holding sheet | seat as described in 2 ..

(Appendix 29)
The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The base material forming portion is provided with a portion in which the support body or the holding body is omitted from the base material so that the base material bends along a living body surface based on the three-dimensional shape information. 29. A device for producing an active ingredient holding sheet according to any one of appendices 26 to 28.

(Appendix 30)
The biological information includes information indicating a distribution for each symptom on a biological surface to which the active ingredient holding sheet is applied,
Supplementary notes 19 to 29, wherein the efficacy component liquid application unit applies, to the base material, an efficacy component liquid of a type corresponding to a symptom for each region corresponding to a symptom of a biological surface based on the biological information. The manufacturing apparatus of the active ingredient holding sheet in any one of.

(Appendix 31)
The biological information includes information indicating the degree of symptom on the biological surface of the target of application of the active ingredient holding sheet,
The apparatus for producing an efficacy component holding sheet according to supplementary note 30, wherein the efficacy component liquid application unit adjusts the amount of each efficacy component liquid according to the degree of symptoms on the surface of the living body.

(Appendix 32)
The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
The entire base material is composed of a holding body that can be impregnated with an active ingredient liquid,
Based on the biological information, the efficacy component liquid application unit applies to the base material an amount of the efficacy component liquid corresponding to the symptom in an amount corresponding to the degree of the symptom for each region according to the symptom of the biological surface. And
26. The efficacy according to any one of appendices 21 to 25, wherein the base material forming part adjusts the thickness of the base material in each region according to the amount of the efficacy component liquid applied to each region. Component holding sheet manufacturing equipment.

(Appendix 33)
The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
Based on the biological information, the efficacy component liquid application unit applies, for each region corresponding to a symptom on the surface of a living body, an effective component liquid of a type corresponding to the symptom to the base material in an amount corresponding to the degree of the symptom. Yes,
30. The effect according to any one of appendices 26 to 29, wherein the base material forming part adjusts the thickness of the holding body in each region according to the amount of the effective component liquid impregnated in each region. Component holding sheet manufacturing equipment.

(Appendix 34)
In the case where the same component is impregnated with a plurality of types of efficacy component liquids, the higher efficacy component liquids are attached to the base material in the thickness direction of the base material. 34. The device for producing an active ingredient-holding sheet according to any one of appendices 30 to 33, wherein each of the active ingredient liquids is applied to the base material so as to be disposed near the surface of the active ingredient.

(Appendix 35)
A device for producing an active ingredient holding sheet to be attached to a living body,
An apparatus for producing an effect ingredient-holding sheet, comprising an effect ingredient liquid imparting section for imparting and impregnating a plurality of kinds of effect ingredient liquids to different regions with respect to a sheet-like base material.

(Appendix 36)
The production of the active ingredient-holding sheet according to any one of appendices 19 to 35, further comprising a drug application unit that applies a powdered drug containing the active ingredient to the base material impregnated with the active ingredient liquid. apparatus.

(Appendix 37)
An active ingredient holding sheet that is affixed to a living body,
It has a sheet-like base material,
An active ingredient holding sheet, wherein the base material is impregnated with an active ingredient liquid according to biological information.

(Appendix 38)
Supplementary note 37 characterized in that the base material has a notch for forming the base material along the living body surface, which is formed according to the three-dimensional shape of the living body surface to which the active ingredient holding sheet is attached. The active ingredient holding sheet as described.

(Appendix 39)
39. The active ingredient holding sheet according to appendix 37 or 38, wherein the base material has an opening formed in a region that avoids the covering of the base material on the surface of the living body to which the active ingredient holding sheet is attached. .

(Appendix 40)
Any one of appendices 37 to 39, wherein an uneven shape corresponding to the uneven shape of the living body surface to which the active ingredient holding sheet is attached is formed on the surface of the base material to be attached to the living body. The active ingredient holding sheet as described in 1.

(Appendix 41)
The substrate is
A holding body impregnated with an active ingredient liquid;
The active ingredient holding sheet according to any one of appendices 37 to 40, further comprising a support that supports the holding body.

(Appendix 42)
The active ingredient holding sheet according to appendix 41, wherein the support is formed of a liquid-impermeable film.

(Appendix 43)
43. The active ingredient holding according to appendix 41 or 42, wherein the base is provided with a portion in which the support is made thinner than other portions so that the base bends along the surface of the living body. Sheet.

(Appendix 44)
44. The appendix according to any one of appendices 41 to 43, wherein the base member is provided with a portion from which the support member or the holding member is omitted so that the base member bends along the living body surface. Active ingredient holding sheet.

(Appendix 45)
Any one of Supplementary notes 37 to 44, wherein the base material is impregnated with a kind of efficacy component liquid corresponding to the symptom for each region according to the symptom on the surface of the living body to which the efficacy component holding sheet is applied. The active ingredient holding sheet as described.

(Appendix 46)
46. The efficacy component holding sheet according to supplementary note 45, wherein the amount of each efficacy component liquid is adjusted according to the degree of symptoms on the surface of the living body to which the efficacy component holding sheet is applied.

(Appendix 47)
The entire base material is composed of a holding body that can be impregnated with an active ingredient liquid,
For each region corresponding to the symptom on the surface of the living body to which the present active ingredient holding sheet is applied, the base material is impregnated with an amount of the active ingredient liquid according to the symptom in an amount corresponding to the degree of the symptom,
41. The active ingredient holding sheet according to any one of appendices 37 to 40, wherein the thickness of the base material in each region is adjusted according to the amount of the active ingredient liquid in each region.

(Appendix 48)
For each region corresponding to the symptom of the biological surface to be applied to the active ingredient holding sheet, the holding body of the base material is impregnated with an amount of the active ingredient liquid according to the symptom in an amount corresponding to the degree of the symptom,
45. The active ingredient holding sheet according to any one of appendices 41 to 44, wherein the thickness of the holding body in each area is adjusted according to the amount of the active ingredient liquid in each area.

(Appendix 49)
In the region of the base material that is impregnated with a plurality of types of efficacy component liquids, the higher the priority of the efficacy component liquid, the closer to the surface of the base material that is attached to the living body in the thickness direction of the base material. 49. The active ingredient holding sheet according to any one of appendices 45 to 48, which is disposed in

(Appendix 50)
An active ingredient holding sheet that is affixed to a living body,
It has a sheet-like base material,
The base material is provided with a plurality of regions impregnated with different types of active ingredient liquids.

(Appendix 51)
51. The efficacy component holding sheet according to any one of supplementary notes 37 to 50, wherein a powdery medicine containing the efficacy component is applied to a base material impregnated with the efficacy component liquid.

DESCRIPTION OF SYMBOLS 1 Face pack manufacturing apparatus 2 Measurement part 3 Print engine part 4 Print engine moving mechanism part 5 Supply part 6 Conveyance part 7 Receiving part 8 Control part 11 Three-dimensional imaging part 12 Skin moisture content measurement part 16 Base material formation part 17 Effective ingredient liquid 17 Application part 21 Base material head 22, 22A, 22B UV irradiation part 23, 23A, 23B Drying part 26, 26A-26D Effective ingredient head 46 Belt 46a Forming surface 61 Face pack 62 Base material 63 Support body 63a Support body reduction part 63b Support Body omission part 64 Holding body 64a Convex part 64b Holding body omission part 71, 71A-71E Cut part 72, 72A-72C Opening part 76, 76A-76D Efficacy component liquid

Claims (51)

A method for producing an active ingredient holding sheet to be attached to a living body,
The manufacturing method of the active ingredient holding sheet | seat characterized by including the process of impregnating the active ingredient liquid according to biometric information with respect to a sheet-like base material.   The step of impregnating the efficacy component liquid is a step of ejecting the efficacy component liquid onto the base material by a droplet ejection head and impregnating the base material with the efficacy component liquid. A method for producing an active ingredient holding sheet.   The method for producing an active ingredient-holding sheet according to claim 1, further comprising a step of forming the base material. The step of forming the substrate comprises
4. The active ingredient holding sheet according to claim 3, wherein the base material is formed by discharging a liquid, which is a material of the base material, onto a surface on which the active ingredient holding sheet is formed by a droplet discharge head. Production method. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The effect according to claim 3 or 4, wherein, in the step of forming the base material, a notch for forming the base material along the surface of the living body is formed on the base material based on the three-dimensional shape information. A method for producing an ingredient holding sheet. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
6. The method according to claim 3, wherein, in the step of forming the base material, an opening is formed in a region where the base material is not covered with the living body based on the three-dimensional shape information. The manufacturing method of the active ingredient holding sheet | seat of description. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
In the step of forming the base material, a concavo-convex shape corresponding to the concavo-convex shape of the surface of the living body is formed on the surface of the base material that is attached to the living body based on the three-dimensional shape information. Item 7. A method for producing an effect ingredient-holding sheet according to any one of Items 3 to 6. The base material has a holding body impregnated with an efficacy component liquid, and a support body that supports the holding body,
The step of forming the substrate comprises
Forming the sheet-like support;
The method for producing an effect ingredient-holding sheet according to any one of claims 3 to 7, further comprising a step of forming the holding body by laminating the support.   9. The method for producing an active ingredient-holding sheet according to claim 8, wherein the step of forming the support is a step of forming the support by a liquid-impermeable film. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The step of forming the support is characterized in that, based on the three-dimensional shape information, a portion in which the support is made thinner than other portions is provided so that the base material bends along the living body surface. The manufacturing method of the active ingredient holding sheet of 8 or 9. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
In the step of forming the base material, a portion in which the support body or the holding body is omitted is provided on the base material so that the base material bends along the living body surface based on the three-dimensional shape information. The manufacturing method of the active ingredient holding sheet of any one of Claims 8 thru | or 10. The biological information includes information indicating a distribution for each symptom on a biological surface to which the active ingredient holding sheet is applied,
In the step of impregnating the efficacy component liquid, the base material is impregnated with a kind of efficacy component liquid corresponding to the symptom for each region according to the symptom on the surface of the living body based on the biological information. The manufacturing method of the active ingredient holding sheet | seat of any one of 1 thru | or 11. The biological information includes information indicating the degree of symptoms on the surface of the biological target to which the active ingredient holding sheet is applied,
13. The method for producing an efficacy component holding sheet according to claim 12, wherein in the step of impregnating the efficacy component solution, the amount of each efficacy component solution is adjusted according to the degree of symptoms on the surface of the living body. The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
The entire base material is composed of a holder that can be impregnated with an effect ingredient liquid,
In the step of impregnating the efficacy component liquid, the base material is impregnated with an amount of the efficacy component liquid according to the symptom in an amount corresponding to the symptom for each region according to the symptom of the living body based on the biological information. Process,
The thickness of the base material in each region is adjusted according to the amount of the active ingredient liquid impregnated in each region in the step of forming the base material. The manufacturing method of the active ingredient holding sheet | seat as described in 2 .. The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
In the step of impregnating the efficacy component liquid, the base material is impregnated with an amount of the efficacy component liquid according to the symptom in an amount corresponding to the symptom for each region according to the symptom of the living body based on the biological information. Process,
The thickness of the holding body in each region is adjusted according to the amount of the active ingredient liquid impregnated in each region in the step of forming the holding body. The manufacturing method of the active ingredient holding sheet | seat as described in 2 ..   In the step of impregnating the efficacy component liquid, in the case where a plurality of types of efficacy component liquids are impregnated in the same region, the higher priority efficacy component liquid is attached to the base body in the thickness direction of the base material. The method for producing an active ingredient-holding sheet according to any one of claims 12 to 15, wherein the base material is impregnated with each of the active ingredient liquids so as to be disposed near a surface on the side to be provided. A method for producing an active ingredient holding sheet to be attached to a living body,
The manufacturing method of an active ingredient holding sheet | seat characterized by including the process of impregnating a mutually different area | region with multiple types of active ingredient liquid with respect to a sheet-like base material.   The active ingredient holding sheet according to any one of claims 1 to 17, further comprising a step of applying a powdered drug containing the active ingredient to the base material impregnated with the active ingredient liquid. Production method. A device for producing an active ingredient holding sheet to be attached to a living body,
An apparatus for producing an efficacy component holding sheet, comprising: an efficacy component liquid imparting section that imparts and impregnates an efficacy component liquid according to biological information to a sheet-like base material.   The apparatus for producing an active ingredient-holding sheet according to claim 19, wherein the active ingredient-liquid application unit discharges and applies the active ingredient liquid to the substrate by a droplet discharge head.   21. The apparatus for producing an active ingredient-holding sheet according to claim 19 or 20, further comprising a base material forming part for forming the base material.   The said base material formation part discharges the liquid which is the material of the said base material on the formation surface of the said active ingredient holding sheet with a droplet discharge head, and forms a base material, It is characterized by the above-mentioned. The manufacturing apparatus of the active ingredient holding sheet | seat as described in 2 .. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The efficacy ingredient according to claim 21 or 22, wherein the base material formation part forms a cut part for making the base material follow a living body surface based on the three-dimensional shape information on the base material. Holding sheet manufacturing equipment. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The said base material formation part forms an opening part in the area | region which avoids the coating | cover with respect to the biological body of the said base material based on the said three-dimensional shape information, The any one of Claims 21 thru | or 23 characterized by the above-mentioned. Equipment for producing active ingredient holding sheets. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The said base material formation part forms the uneven | corrugated shape according to the uneven | corrugated shape of the biological body surface on the surface by the side of the said base material affixed on the biological body based on the said three-dimensional shape information. The manufacturing apparatus of the active ingredient holding sheet | seat of any one of thru | or 24. The base material has a holding body impregnated with an efficacy component liquid, and a support body that supports the holding body,
The substrate forming part is
The said base material is formed by forming the said sheet-like support body, laminating | stacking on the said support body, and forming the said holding body, The any one of Claims 21 thru | or 25 characterized by the above-mentioned. Equipment for producing active ingredient holding sheets.   The said base material formation part forms the said support body with a liquid-impermeable film, The manufacturing apparatus of the active ingredient holding sheet | seat of Claim 26 characterized by the above-mentioned. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The said base material formation part provides the part which made the said support body thinner than another part so that the said base material might bend along the biological body surface based on the said three-dimensional shape information, or characterized by the above-mentioned. 27. An apparatus for producing an active ingredient-holding sheet according to 27. The biological information includes three-dimensional shape information of a biological surface to which the active ingredient holding sheet is attached,
The base material forming portion is provided with a portion in which the support body or the holding body is omitted from the base material so that the base material bends along a living body surface based on the three-dimensional shape information. The apparatus for producing an active ingredient-holding sheet according to any one of claims 26 to 28. The biological information includes information indicating a distribution for each symptom on a biological surface to which the active ingredient holding sheet is applied,
The said efficacy component liquid provision part provides the said base material with the kind of efficacy component liquid according to the symptom for every area | region according to the symptom of the biological body based on the said biological information. An apparatus for producing an active ingredient-holding sheet according to any one of 29. The biological information includes information indicating the degree of symptom on the biological surface of the target of application of the active ingredient holding sheet,
31. The device for producing an efficacy component holding sheet according to claim 30, wherein the efficacy component liquid application unit adjusts the amount of each efficacy component solution according to the degree of symptoms on the surface of the living body. The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
The entire base material is composed of a holding body that can be impregnated with an active ingredient liquid,
Based on the biological information, the efficacy component liquid application unit applies to the base material an amount of the efficacy component liquid corresponding to the symptom in an amount corresponding to the degree of the symptom for each region according to the symptom of the biological surface. And
The said base material formation part adjusts the thickness of the said base material in each area | region according to the quantity of the active ingredient liquid provided to each area | region, The any one of Claims 21 thru | or 25 characterized by the above-mentioned. The manufacturing apparatus of the active ingredient holding sheet of description. The biological information includes information indicating the distribution for each symptom on the surface of the biological target to which the efficacy component holding sheet is applied, and the degree of each symptom,
Based on the biological information, the efficacy component liquid application unit applies, for each region corresponding to a symptom on the surface of a living body, an effective component liquid of a type corresponding to the symptom to the base material in an amount corresponding to the degree of the symptom. Yes,
30. The method according to claim 26, wherein the base material forming unit adjusts the thickness of the holding body in each region according to the amount of the active ingredient liquid impregnated in each region. The manufacturing apparatus of the active ingredient holding sheet of description.   In the case where the same component is impregnated with a plurality of types of efficacy component liquids, the higher efficacy component liquids are attached to the base material in the thickness direction of the base material. 34. The device for producing an active ingredient-holding sheet according to any one of claims 30 to 33, wherein each of the active ingredient liquids is applied to the substrate so as to be disposed near the surface of the active ingredient. A device for producing an active ingredient holding sheet to be attached to a living body,
An apparatus for producing an effect ingredient-holding sheet, comprising an effect ingredient liquid imparting section for imparting and impregnating a plurality of kinds of effect ingredient liquids to different regions with respect to a sheet-like base material.   36. The retention of the active ingredient according to any one of claims 19 to 35, further comprising a drug application part for applying a powdery drug containing the active ingredient to the base material impregnated with the active ingredient liquid. Sheet manufacturing equipment. An active ingredient holding sheet that is affixed to a living body,
It has a sheet-like base material,
An active ingredient holding sheet, wherein the base material is impregnated with an active ingredient liquid according to biological information.   The said base material has an incision part formed according to the three-dimensional shape of the biological surface of the biological object of sticking of this active ingredient holding sheet | seat for making the said base material follow the biological surface. The active ingredient holding sheet as described in 1.   The said base material has an opening part formed in the area | region which avoids the coating | coated of the said base material in the biological surface of the sticking target of this active ingredient holding sheet, The active ingredient holding | maintenance of Claim 37 or 38 characterized by the above-mentioned. Sheet.   40. The concavo-convex shape corresponding to the concavo-convex shape of the surface of the living body to which the active ingredient holding sheet is applied is formed on the surface of the base material to be attached to the living body. The active ingredient holding sheet according to claim 1. The substrate is
A holding body impregnated with an active ingredient liquid;
The active ingredient holding sheet according to any one of claims 37 to 40, further comprising a support for supporting the holding body.   The active ingredient holding sheet according to claim 41, wherein the support is formed of a liquid-impermeable film.   43. The active ingredient according to claim 41 or 42, wherein the base is provided with a portion in which the support is thinner than other portions so that the base is bent along the surface of the living body. Holding sheet.   The said base material is provided with the part which abbreviate | omitted the said support body or the said holding body so that the said base material might bend along a biological body surface. The active ingredient holding sheet as described in 1.   45. The substrate according to any one of claims 37 to 44, wherein the base material is impregnated with an effect ingredient liquid of a kind corresponding to the symptom for each region corresponding to the symptom on the surface of the living body to which the present active ingredient holding sheet is applied. The active ingredient holding sheet according to Item 1.   46. The active ingredient holding sheet according to claim 45, wherein the amount of each active ingredient liquid is adjusted according to the degree of symptoms on the surface of the living body to which the present active ingredient holding sheet is applied. The entire base material is composed of a holding body that can be impregnated with an active ingredient liquid,
For each region corresponding to the symptom on the surface of the living body to which the present active ingredient holding sheet is applied, the base material is impregnated with an amount of the active ingredient liquid according to the symptom in an amount corresponding to the degree of the symptom,
41. The efficacy component holding sheet according to any one of claims 37 to 40, wherein the thickness of the base material in each region is adjusted according to the amount of efficacy component liquid in each region. For each region corresponding to the symptom of the biological surface to be applied to the active ingredient holding sheet, the holding body of the base material is impregnated with an amount of the active ingredient liquid according to the symptom in an amount corresponding to the degree of the symptom,
The effective ingredient holding sheet according to any one of claims 41 to 44, wherein the thickness of the holding body in each area is adjusted according to the amount of the effective ingredient liquid in each area.   In the region of the base material that is impregnated with a plurality of types of efficacy component liquids, the higher the priority of the efficacy component liquid, the closer to the surface of the base material that is attached to the living body in the thickness direction of the base material. 49. The active ingredient holding sheet according to any one of claims 45 to 48, wherein the active ingredient holding sheet is disposed in the base. An active ingredient holding sheet that is affixed to a living body,
It has a sheet-like base material,
The base material is provided with a plurality of regions impregnated with different types of active ingredient liquids.   51. The efficacy component holding sheet according to any one of claims 37 to 50, wherein a powdery medicine containing an efficacy component is applied to a base material impregnated with the efficacy component liquid.